Foresight Acquisition Corp.
Status: Closed Deal
U=S+W/3
W=S@11.5
| IPO Proceeds, $M | $316.25M |
|---|---|
| IPO Date | Feb 10, 2021 |
| CEO | Michael Balkin |
| Left Lead | Cowen |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 24 months |
| IPO Sector | Consumer ▶ |
| IPO Geography | Global |
| Target Company | P3 Health Partners |
| Deal Announced | May 25, 2021 |
| Deal Size, $M | $2,336.00M |
| Deal Sector | Healthcare |
| Deal Geography | US/Canada |
| SEC Filings |
www.sec.gov 
|
| Approval Vote | Dec 3, 2021 |
| Amendment Vote | TBD |
| Closing Date | Dec 3, 2021 |
Formerly FORE
PIII
PIIIW
| Price | $9.33 $0.19 |
|---|---|
| Last closing price | $8.86 |
| H/L, today | $8.71 / $9.31 |
| H/L, 52-week | $0.70 / $5.76 |
| Volume, today | 9,560 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in to view structure, cap table, and calendar of events.